Cart
sales@molnova.com
Ketohexokinase inhibitor 1
CAS No. 2102501-84-6
Ketohexokinase inhibitor 1( —— )
Catalog No. M23954 CAS No. 2102501-84-6
Ketohexokinase inhibitor 1 is a ketohexokinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 335 | In Stock |
|
| 2MG | 160 | In Stock |
|
| 5MG | 306 | In Stock |
|
| 10MG | 519 | In Stock |
|
| 25MG | 928 | In Stock |
|
| 50MG | 1228 | In Stock |
|
| 100MG | 1655 | In Stock |
|
| 200MG | 2213 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKetohexokinase inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionKetohexokinase inhibitor 1 is a ketohexokinase inhibitor.
-
DescriptionKetohexokinase inhibitor 1 is a ketohexokinase inhibitor (IC50s: 8.4 nM and 66 nM for KHK-C and KHK-A, respectively).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorKHK-A|KHK-C
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2102501-84-6
-
Formula Weight356.34
-
Molecular FormulaC16H19F3N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (350.79 mM)
-
SMILESC[C@@H](CC1)N1c1nc(N(C2)C[C@@H]3[C@H]2C3CC(O)=O)cc(C(F)(F)F)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
-
Taltirelin
Taltirelin is at thyrotropin-releasing hormone receptor (TRH-R) superagonist (IC50 of 910 nM and EC50 of 36 nM for stimulating an increase in cytosolic Ca2+ concentration (Ca2+ release).
-
Ulixertinib
Ulixertinib (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.
